Pharmacology & Medication Management Flashcards
7 cards from real IHSA practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Pharmacology & Medication Management flashcards as text
Which anti-doping list status applies to a substance that is prohibited only when an athlete is competing (in-competition), but permitted during training?
Answer: In-Competition Only Prohibition
Some substances, particularly stimulants and narcotics, are only prohibited in-competition under the WADA prohibited list.
Ibuprofen taken chronically by an endurance athlete poses the greatest risk of:
Answer: Gastrointestinal ulceration and renal impairment
Chronic NSAID use, especially during endurance events with dehydration, significantly raises the risk of GI ulcers and acute kidney injury.
A TUE application for a prohibited substance should be submitted:
Answer: In advance before use, except in emergency situations allowing retroactive TUEs
TUEs must typically be granted before using a prohibited substance; retroactive TUEs are only allowed in genuine medical emergencies.
An athlete asks about using a CBD (cannabidiol) product. Which statement is accurate under current WADA rules?
Answer: CBD itself is no longer prohibited, but THC remains on the prohibited list
WADA removed CBD from the prohibited list in 2018; however, THC and other cannabinoids remain prohibited in-competition.
The 'therapeutic window' of a drug refers to:
Answer: The range of doses between minimum effective concentration and minimum toxic concentration
The therapeutic window defines safe and effective dosing: above it causes toxicity, below it lacks efficacy.
Which route of administration provides the fastest onset of action in emergency situations?
Answer: Intravenous (into a vein)
Intravenous administration delivers drugs directly into the bloodstream, providing the fastest onset of action.
A coach must maintain athlete medication confidentiality under HIPAA. Which action violates this obligation?
Answer: Disclosing an athlete's medication list to media without consent
Disclosing protected health information including medications to media without athlete consent violates HIPAA confidentiality requirements.